Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Otsuka Pharmaceutical Co., Ltd.

Clinical trials sponsored by Otsuka Pharmaceutical Co., Ltd., explained in plain language.

Now part of Otsuka Holdings Co., Ltd. 4578 TOKYO

Pharmaceutical company developing treatments for mental health and other diseases.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 5 Not yet recruiting 2 Not yet finished but already full! 2 Completed 5 Terminated 1

Experimental lymphoma drug ASTX660 tested in tiny, terminated trial

Disease control Terminated

This early-phase trial tested the drug ASTX660 in just 8 people with T-cell lymphoma that had returned or not responded to prior treatments. The study aimed to find a safe dose and check for side effects, but it was stopped early. Because it was so small and incomplete, we cannot…

Phase: PHASE1, PHASE2 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 09:08 UTC